| Greetings!
AAPS Pharma is excited to present an in-depth workshop focused on the transformative updates introduced by the ICH E6(R3) Good Clinical Practice (GCP) guidelines, which are reshaping the landscape of clinical trials. This workshop will provide clinical research professionals with a thorough understanding of the latest changes in trial design, oversight, and regulatory compliance. Participants will explore advanced topics such as modernized trial methodologies, digital innovation, and the integration of Real-World Data (RWD) and Real-World Evidence (RWE), all aimed at optimizing patient-centered approaches and enhancing trial flexibility.
Through case studies and strategic discussions, attendees will gain practical insights into applying these innovations in real clinical research settings. The workshop will emphasize how to implement decentralized clinical trials (DCTs), digital health technologies (DHTs), and telemedicine to improve accessibility, retention, and trial diversity, ensuring that trials are designed with the patient experience in mind.
This event is designed for experienced clinical research professionals, including CRAs, CRCs, Clinical Project Managers, and specialists in Regulatory Affairs, Data Management, and Quality Assurance, as well as clinical operations leaders who aim to integrate the latest GCP standards into their practices. By attending, participants will be equipped with the knowledge to future-proof their clinical operations and maintain regulatory excellence.
By the end of the workshop, attendees will have gained a deep, operational understanding of the ICH E6(R3) GCP updates. They will also be able to integrate modern trial methodologies and digital innovations into their practices, apply RWD and RWE principles, and design and conduct patient-centric, decentralized trials aligned with regulatory standards. | 
No comments:
Post a Comment